pentobarbital will reduce the extent or outcome of buprenorphine, lengthy-acting injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Individuals who transfer to buprenorphine prolonged-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers need to be monitored to be sur… Read More